Literature DB >> 23290076

Analyses of FLG mutation frequency and filaggrin expression in isolated ichthyosis vulgaris (IV) and atopic dermatitis-associated IV.

M Li1, R Cheng, M Shi, J Liu, G Zhang, Q Liu, H Yu, Z Yao.   

Abstract

BACKGROUND: Ichthyosis vulgaris (IV; OMIM 146700) is a very common inherited skin disorder. Loss-of-function mutations in the filaggrin gene (FLG) have been identified as the cause of IV. In a previous study, we found that the percentage of FLG null mutations was lower in IV associated with atopic dermatitis (AD) than in IV not associated with AD (isolated IV). We speculated that some clinical manifestations of IV in patients with AD are not induced by FLG mutations.
OBJECTIVES: In order to clarify this issue, we collected 21 IV pedigrees, 33 patients with sporadic isolated IV and 116 patients with AD-associated IV to analyse FLG mutation frequency and filaggrin expression in isolated IV and AD-associated IV.
METHODS: A comprehensive sequencing of the FLG gene in all patients was performed using an overlapping polymerase chain reaction (PCR) strategy. We also studied the immunohistochemistry of profilaggrin/filaggrin protein expression in the skin and measured the mRNA expression using real-time PCR in seven patients, including one patient with IV harbouring the mutation c.3321delA, two patients with AD-associated IV harbouring c.3321delA and c.6834del5, and four patients with AD-associated IV without FLG mutations.
RESULTS: The percentage of mutations in the FLG gene was 74% and 43% in patients with isolated IV and patients with AD-associated IV, respectively. Immunohistochemical staining revealed that profilaggrin/filaggrin peptides were remarkably reduced in the epidermis of all the patients. All the patients with either AD or IV showed lower FLG mRNA expression compared with the normal control.
CONCLUSIONS: These results indicate that factors other than FLG gene mutations can downregulate profilaggrin/filaggrin expression, leading to the ichthyosiform phenotype in the context of AD.
© 2013 The Authors. BJD © 2013 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23290076     DOI: 10.1111/bjd.12206

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

1.  Filaggrin gene polymorphism associated with Epstein-Barr virus-associated tumors in China.

Authors:  Yang Yang; Wen Liu; Zhenzhen Zhao; Yan Zhang; Hua Xiao; Bing Luo
Journal:  Virus Genes       Date:  2017-04-28       Impact factor: 2.332

2.  Bilateral lower extremity hyperkeratotic plaques: a case report of ichthyosis vulgaris.

Authors:  Hayley Leight; Zachary Zinn; Omid Jalali
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-09-15

3.  A mechanistic target of rapamycin complex 1/2 (mTORC1)/V-Akt murine thymoma viral oncogene homolog 1 (AKT1)/cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in patients with atopic dermatitis.

Authors:  Aishath S Naeem; Cristina Tommasi; Christian Cole; Stuart J Brown; Yanan Zhu; Benjamin Way; Saffron A G Willis Owen; Miriam Moffatt; William O Cookson; John I Harper; Wei-Li Di; Sara J Brown; Thomas Reinheckel; Ryan F L O'Shaughnessy
Journal:  J Allergy Clin Immunol       Date:  2016-11-29       Impact factor: 10.793

Review 4.  Classifying atopic dermatitis: a systematic review of phenotypes and associated characteristics.

Authors:  A L Bosma; A Ascott; R Iskandar; K Farquhar; J Matthewman; M W Langendam; A Mulick; K Abuabara; H C Williams; P I Spuls; S M Langan; M A Middelkamp-Hup
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-02-25       Impact factor: 9.228

5.  An Analysis of the Filaggrin Gene Polymorphism in Korean Atopic Dermatitis Patients.

Authors:  Kui Young Park; Kapsok Li; Joon Seok; Seong Jun Seo
Journal:  J Korean Med Sci       Date:  2016-05-09       Impact factor: 2.153

6.  A unique case of a digital tourniquet in ichthyosis vulgaris.

Authors:  L F McClymont; M Ng
Journal:  JPRAS Open       Date:  2019-10-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.